Skip to content

Effects of Dexmetomidine and Remifentanil Used for Controlled Hypotension in Septorhinoplasty Surgery on Cardiac Electrophysiology: Prospective Randomized Study

Effects of Dexmetomidine and Remifentanil Used for Controlled Hypotension in Septorhinoplasty Surgery on Cardiac Electrophysiology: Prospective Randomized Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06138574
Acronym
Effects of Dex
Enrollment
72
Registered
2023-11-18
Start date
2023-12-01
Completion date
2024-03-30
Last updated
2023-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rhinoplasty Surgery

Brief summary

Our aim in this treatment was to reveal the effects of remifentanil and dexmetomidine, which we used to provide controlled hypotension in septorhinoplasty surgery, on cardiac electrophysiology. We planned to compare the patients by recording preoperative and postoperative ECGs. We also planned to record the patients' intraoperative blood pressure, saturation, and pulse rate, rickeragitation scale, and vas score.

Interventions

DRUGDexmedetomidine

After the induction of general anesthesia, one group (Group: 1) will be administered dexmedotomidin infizyon and group (Group :2)remifentanil

DRUGRemifentanil

Remifentanil

Sponsors

Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
17 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* patients with an ASA score of I and between the ages of 17-45 years, who were to undergo general anesthesia with sevofulurane were included in the study.

Exclusion criteria

Patients aged \<17 and \>45 years, patients with liver and/or kidney failure, obese patients (BMI \>30), trauma patients, ASA II-III-IV patients, patients with bleeding disorders, those using drugs that may affect the coagulation system, patients with cardiomyopathy, cerebrovascular disease, immobility, and malnutrition were excluded from the study. \-

Design outcomes

Primary

MeasureTime frameDescription
icebpreoperative and postoperative (immediatly after extubation)Qt\\Qrs

Secondary

MeasureTime frameDescription
Riker Agitation ScaleImmediately after extubation7 -Dangerous Agitation, 6 - Very Agitated, 5 - Agitated, 4 - Calm and Cooperative, 3 - sedated, 2- Very Sedated, 1 -Unarousable
mean arterial pressurewhen you come to the operating room table after anesthesia induction Intraoperative 30 minutes after extubasionmmHg
heart ratewhen you come to the operating room table after anesthesia induction Intraoperative 30 minutes after extubasionbeats\\minute
Numeric Rating ScalePostoperative 0-2 hoursThey will be numbered from 1 to 10. 1 mildest 10 most severe pain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026